Medication adherence-where prescribed medications are taken at the right doses and times in the manner specified-has been shown to improve health outcomes and reduce health-care costs.
| INTRODUC TI ON
Medication adherence-where prescribed medications are taken at the right doses and times in the manner specified-has been shown to improve health outcomes and reduce health-care costs. 1, 2 Indeed, a recent Cochrane review concluded that "increasing the effectiveness of adherence interventions may have a far greater impact on the health of the population than any improvement in specific medical treatments." 3 Non-adherence, which can take the form of non-initiation and non-persistence, is closely linked with treatment efficacy and disease progression, 4 as well as inappropriate uptitration, with subsequent risk of interactions and adverse drug reactions. 5 Adherence is a particular concern in older persons, with the prevalence of factors associated with poor adherence, such as multimorbidity and greater regimen complexity, increasing with age. [6] [7] [8] Multiple factors at the drug, patient, provider, and institutional levels may explain non-adherence in the specific population of older people, including: (a) increased vulnerability to drug-related problems through pharmacodynamic and pharmacokinetic changes 9 ;
(b) high prevalence of comorbidity with subsequent polypharmacy and functional impairment [10] [11] [12] ; (c) elevated risk of drug interactions with increasing medication burden 13, 14 ; and (d) high rates of service use across settings, leading to multiple providers and regimen complexity. 15 These problems rarely occur in isolation and can be both the cause and effect of non-adherence, leading to a cycle of escalating adversity. Despite this, studies that explicitly consider this older population appear to be under-represented, and those that do tend to focus on a single disease. We set out to quantify the factors potentially associated with adherence by undertaking a systematic review of studies addressing these issues specifically in persons aged ≥75 years, enabling synthesis of results across different diseases and health-care settings.
| ME THODS

| Search strategy and selection criteria
We used the following search terms in PubMed, adapting them for EMBASE and Web of Science: (Complia*/Non-complia*) (Adher*/ Non-adher*) (Concordan*/Non-concordan*) (Elder*/Old*/Geriatr*/ Aged/Senior). References for included articles and relevant literature reviews were also hand-searched for additional relevant publications. The search was completed in November 2017.
After screening title and abstract, the full text was reviewed. The majority of screening was carried out by A.S., with a sample independently carried out by a second reviewer (R.R.) and cross-checked to ensure validity and reproducibility. Any uncertainty was resolved following discussion with a third reviewer (D.D.). Screening and fulltext review was undertaken using Covidence. 16 We used the following inclusion criteria:
• Population-Studies that only included participants aged 75 or over; studies in which the mean age of participants was ≥75 years;
or studies that reported data separately for participants aged ≥75.
• Intervention-Both interventional and non-interventional studies were considered.
• Outcomes-Studies with an operational definition of adherence.
• Analysis-Studies quantifying associations between any measured factors and adherence.
We applied the following exclusion criteria: non-English publications; articles that had not undergone full peer review, such as conference abstracts/posters; publications relating solely to the cost of medicines or cost analysis; and studies published prior to 2000 due to evolutions in prescribing practice over the last two decades.
| Data extraction
Data were extracted and entered into a custom template made by the first author. participants), method of data collection, definition of adherence, and any measured associations (if any). Study quality was assessed by the same independent reviewers using the Newcastle-Ottawa Scale 17 rating: selection, comparability, and outcome (maximum score = 9 points).
| RE SULTS
Of the 6346 publications identified, 540 were eligible for fulltext review and 25 met the criteria for inclusion (Figure 1 majority of those eligible for inclusion were observational studies (one randomized controlled trial, 11 cohort, and 13 crosssectional) based in Europe or North America. Participants were community dwelling (range n = 27 to n = 140 000), although some studies assessed specific groups within the community, such as those post-hospitalization or memory clinic users ( and (c) data from interviews or self-report questionnaires.
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| Patient factors
Factors positively associated with adherence included being of European descent, 21, 32, 38 and having high health literacy and information about the treatment purpose and consequences of omission. 18, 30 With regard to specific diseases, only cancer was shown to have a positive association with adherence.
32
Demographic factors negatively associated with adherence included older age 19, 25, 27, 35, 38 and being male, 21, 25, 28, 29, 40 although these associations were weak (Figure 2 ). Health behaviors negatively associated with adherence were excessive alcohol consumption. 22 Other factors negatively associated with adherence included the neurotic personality trait (other personality traits did not have a significant impact), 27 recent hospitalization, and lack of contact with a general practitioner. 31, 32 Higher levels of comorbidity were also associated with poorer adherence (Figure 3) . 9, 25, 33, 38 Compared with people who did not have these diseases, stroke, 25 falls, 32 sleep disturbance, 32 and chronic obstructive pulmonary disease 21 were all found to have an independent negative effect on adherence due to their presence. There was a suggestion that cognitive impairment shares a negative association with adherence 18, 22, 26, 27 (Figure 4 ), although these results contrasted findings from two smaller studies.
Both of these studies not demonstrating any association featured small sample sizes, one of which recruited patients from a memory clinic (i.e., without a healthy control comparator).
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General education did not appear to be associated with adherence, 18, 27, 32, 35, 42 and nor were psychiatric diagnoses. 18, 22, 41 The two studies reporting body mass index associations had discordant results.
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| Medication factors
The only medication factor positively associated with adherence was having had a medication review in the last 6 months, although this was only assessed in one study. 22 Factors negatively associated with adherence included recently changed medication regimens 31 and those regimens that had been formulated through involvement of greater numbers of prescribing physicians. 18 Patient dissatisfaction with the drug formulation and difficulties with drug storage, such as accumulation of drugs and scattered drug storage, were also negatively associated with adherence. 20, 28, 41 In general, adherence was negatively associated with larger numbers of prescribed drugs, but this was not consistent. Where reports defined polypharmacy with a higher cutoff (such as greater than seven or even nine drugs), polypharmacy was more likely to have a negative association with adherence. 28, 31, 37 The studies that used a continuous scale of overall pill burden were less likely to find an association between polypharmacy and adherence. 21, 22, 35 One study reported improved adherence with increasing pill burden.
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Compliance aids were not consistently associated with adherence ( Figure 5 ). 18, 20, 34, 42 One study found that compliance aids were associated with medications being taken on a given day but not improved adherence to the correct dosage or regimen. 
| Institutional factors
Six studies reported on the presence of a caregiver, five of which found no association with adherence. 22, 27, 29, 34, 37 One study found that a resident caregiver improved adherence focused on patients with mild cognitive impairment. 34 There was no consensus between studies that reported the setting in which the patient lived, and similarly whether the patient lived alone or with someone else. 18, [20] [21] [22] [23] 34 
| D ISCUSS I ON
Factors most consistently negatively associated with adherence in this older population were related to complex regimens with multiple prescribing physicians, and problems with medication storage and formulation. Multimorbidity and cognitive impairment were also negatively associated with adherence. In contrast, recent medication review and knowledge about the purpose of the treatment and consequences of omission were positively associated with adherence.
However, the use of medication compliance aids and, in the absence of cognitive impairment, the presence of a caregiver did not appear to be associated with adherence. Although we sought to examine this question specifically in older populations, we found only a weak negative association with adherence at these ages. Taken together, our findings suggest that interventions for improving adherence should be aimed at patients with multimorbidity and cognitive impairment, with the goal of improving knowledge about the treatment and simplifying regimens.
This review goes beyond the findings of an earlier systematic review by considering studies conducted outside of the USA and focusing solely on patients aged over 75 years. 43 Previous work found it difficult to draw broad conclusions due to differences in the definition and measurement of adherence and the limited number of publications that were included. Our findings support the conclusions that healthrelated knowledge, cognitive impairment, and polypharmacy have an impact on adherence. However, our analysis adds uncertainty to the notion that medication compliance aids are effective. This suggests that future investigations into other forms of adherence support are merited. The utility of compliance aids has been debated in a recent
European Medicines Agency Reflection Paper, in which problems relating to the recognition of medicines due to removal from their original packaging were specifically highlighted. 44 We found that external reminders (such as caregivers and phone call reminders) were more effective in older adults with cognitive impairment. 45 Our results should be treated with caution. As with previous research in this area, 43 Nonetheless, the strongest associations hold despite these operational differences. The major strengths of our approach have been our specific focus on older populations, a previously unexplored group with a high prevalence of adherence issues, and inclusion of studies across a range of English-language health-care systems.
The mechanisms underlying factors with an impact on adherence are strongly interlinked. An individual with multiple medical problems is likely to see several health-care practitioners, all of whom may make changes to their regimen. This is likely to be confusing, thereby leading to poor adherence. Cognitive impairment across domains such as episodic memory and executive function will have consequences that include both intentional and unintentional nonadherence. The prevalence of multimorbidity and cognitive impairment increases with age, and appears to become more important for adherence than age per se. As such, medication review with the opportunity to clarify and simplify prescription regimens and for the patient to ask questions might be most effective in this group. This is consistent with having fewer prescribing physicians and knowledge about the treatment being positively associated with adherence, and should be considered in light of our finding that neither the presence of a carer (in the absence of cognitive impairment) nor compliance aids showed any association with adherence. A recent case report discussed the potential utility of knowing a patient's medication schedule so that the pill burden is not unnecessarily increased when changes need to be made, something that could be achieved with this single-point-of-care model. 46 Ultimately, it may be that the most effective interventions focus on patient empowerment rather than the influence of external factors, even if individuals are living with cognitive impairment or dementia. 47 Overall, this review supports our understanding that nonadherence is prevalent amongst older patients and is multifactorial in origin. We suggest that interventions to improve adherence in this population might be most effective if delivered in the form of a medication review, with the aim of simplifying prescription regimens and providing patient education on the indications of individual therapies. If provided from a single point of care, this would reduce the number of prescribing physicians and monitor the frequency of regimen changes. In addition, switching formulation to that preferred by the patient and screening for drug storage problems could also be effective in optimizing adherence. In particular, it would seem that specific targeting of those with cognitive impairment and multimorbidity would address an at-risk group with unmet needs. 
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